355 related articles for article (PubMed ID: 32839596)
1. Fructose stimulated de novo lipogenesis is promoted by inflammation.
Todoric J; Di Caro G; Reibe S; Henstridge DC; Green CR; Vrbanac A; Ceteci F; Conche C; McNulty R; Shalapour S; Taniguchi K; Meikle PJ; Watrous JD; Moranchel R; Najhawan M; Jain M; Liu X; Kisseleva T; Diaz-Meco MT; Moscat J; Knight R; Greten FR; Lau LF; Metallo CM; Febbraio MA; Karin M
Nat Metab; 2020 Oct; 2(10):1034-1045. PubMed ID: 32839596
[TBL] [Abstract][Full Text] [Related]
2. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate.
Zhao S; Jang C; Liu J; Uehara K; Gilbert M; Izzo L; Zeng X; Trefely S; Fernandez S; Carrer A; Miller KD; Schug ZT; Snyder NW; Gade TP; Titchenell PM; Rabinowitz JD; Wellen KE
Nature; 2020 Mar; 579(7800):586-591. PubMed ID: 32214246
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
4. MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis.
Chanda D; Li J; Oligschlaeger Y; Jeurissen ML; Houben T; Walenbergh SM; Shiri-Sverdlov R; Neumann D
Exp Mol Med; 2016 Sep; 48(9):e258. PubMed ID: 27609031
[TBL] [Abstract][Full Text] [Related]
5. Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin.
Silva-Veiga FM; Miranda CS; Martins FF; Daleprane JB; Mandarim-de-Lacerda CA; Souza-Mello V
J Endocrinol; 2020 Oct; 247(1):11-24. PubMed ID: 32698143
[TBL] [Abstract][Full Text] [Related]
6. Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis.
Li X; Zhang Y; Jin Q; Xia KL; Jiang M; Cui BW; Wu YL; Song SZ; Lian LH; Nan JX
Br J Pharmacol; 2018 May; 175(9):1451-1470. PubMed ID: 29338075
[TBL] [Abstract][Full Text] [Related]
7. Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism.
Jegatheesan P; De Bandt JP
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273805
[TBL] [Abstract][Full Text] [Related]
8. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
[TBL] [Abstract][Full Text] [Related]
9. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
10. Allopurinol Prevents the Lipogenic Response Induced by an Acute Oral Fructose Challenge in Short-Term Fructose Fed Rats.
García-Arroyo FE; Monroy-Sánchez F; Muñoz-Jiménez I; Gonzaga G; Andrés-Hernando A; Zazueta C; Juárez-Rojas JG; Lanaspa MA; Johnson RJ; Sánchez-Lozada LG
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614639
[TBL] [Abstract][Full Text] [Related]
11. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
12. DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1.
Tong X; Zhang D; Shabandri O; Oh J; Jin E; Stamper K; Yang M; Zhao Z; Yin L
Metabolism; 2020 Jun; 107():154222. PubMed ID: 32246987
[TBL] [Abstract][Full Text] [Related]
13. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
[TBL] [Abstract][Full Text] [Related]
14. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
[TBL] [Abstract][Full Text] [Related]
15. Polyphenol-Rich Loquat Fruit Extract Prevents Fructose-Induced Nonalcoholic Fatty Liver Disease by Modulating Glycometabolism, Lipometabolism, Oxidative Stress, Inflammation, Intestinal Barrier, and Gut Microbiota in Mice.
Li W; Yang H; Zhao Q; Wang X; Zhang J; Zhao X
J Agric Food Chem; 2019 Jul; 67(27):7726-7737. PubMed ID: 31203627
[TBL] [Abstract][Full Text] [Related]
16. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
Su YB; Li TH; Huang CC; Tsai HC; Huang SF; Hsieh YC; Yang YY; Huang YH; Hou MC; Lin HC
PLoS One; 2018; 13(4):e0194867. PubMed ID: 29684027
[TBL] [Abstract][Full Text] [Related]
17. Disparate metabolic response to fructose feeding between different mouse strains.
Montgomery MK; Fiveash CE; Braude JP; Osborne B; Brown SH; Mitchell TW; Turner N
Sci Rep; 2015 Dec; 5():18474. PubMed ID: 26690387
[TBL] [Abstract][Full Text] [Related]
18. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
19. CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis.
Ju L; Sun Y; Xue H; Chen L; Gu C; Shao J; Lu R; Luo X; Wei J; Ma X; Bian Z
Sci Rep; 2020 Feb; 10(1):3201. PubMed ID: 32081971
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
